Renal Medullary Carcinoma: Establishing Standards in Practice.

ABSTRACT: Although renal medullary carcinoma (RMC) is a rare subtype of kidney cancer, it is particularly devastating in that it is nearly uniformly lethal. No established guidelines exist for the diagnosis and management of RMC. In April 2016, a panel of experts developed clinical guidelines on the basis of a literature review and consensus statements. The goal was to propose recommendations for standardized diagnostic and management approaches and to establish an international clinical registry and biorepository for RMC. Published data are limited to case reports and small retrospective reviews. The RMC Working Group prepared recommendations to inform providers and patients faced with a low level of medical evidence. The diagnosis of RMC should be considered in all patients younger than 50 years w

SUBMITTER: Beckermann KE 

PROVIDER: S-EPMC5508447 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature